{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:14:44Z","timestamp":1790162084538,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04269-w","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:55:18Z","timestamp":1776156918000},"page":"4781-4793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking mucinous colorectal adenocarcinoma classification: evidence from histopathology and RAS mutations"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0315-9504","authenticated-orcid":false,"given":"Dorra","family":"Wider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Tounsi Guettiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Ardhaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Jaballah-Gabteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihenne","family":"Ben Aissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Ben Ayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ben Jemii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Yaiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Fehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essia","family":"Habachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afifa","family":"Maaloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Ennaifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Boubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"4269_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56722","volume":"16","author":"KA Alshehri","year":"2024","unstructured":"Alshehri KA, Alsulaimani N, Alghamdi WA, Almansouri Z, Zubair SA, Zekri J, et al. Mucinous differentiation in colorectal cancer: a 10-year experience audit at King Faisal Specialist Hospital and Research Centre, Jeddah. Cureus. 2024;16:e56722. https:\/\/doi.org\/10.7759\/cureus.56722.","journal-title":"Cureus"},{"key":"4269_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41587-023-01984-5","volume":"42","author":"R Beatson","year":"2024","unstructured":"Beatson R, Burchell JM. A mucin degrader for cancer therapy. Nat Biotechnol. 2024;42:572\u20133. https:\/\/doi.org\/10.1038\/s41587-023-01984-5.","journal-title":"Nat Biotechnol"},{"key":"4269_CR3","unstructured":"Cancer (IARC) TIA for R on Global Cancer Observatory. https:\/\/gco.iarc.fr\/. Accessed 30 July 2024"},{"key":"4269_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbagen.2014.05.003","volume":"1850","author":"AP Corfield","year":"2015","unstructured":"Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochimica et Biophysica Acta (BBA)\u2014Gen Subj. 2015;1850:236\u201352. https:\/\/doi.org\/10.1016\/j.bbagen.2014.05.003.","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Gen Subj"},{"key":"4269_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cis.2017.12.005","volume":"252","author":"B Demouveaux","year":"2018","unstructured":"Demouveaux B, Gouyer V, Gottrand F,\u00a0Narita T, Desseyn JL.  Gel-forming mucin interactome drives mucus viscoelasticity. Adv Colloid Interface Sci. 2018;252:69\u201382. https:\/\/doi.org\/10.1016\/j.cis.2017.12.005.","journal-title":"Adv Colloid Interface Sci"},{"key":"4269_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3978\/j.issn.2078-6891.2012.030","volume":"3","author":"M Fleming","year":"2012","unstructured":"Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol. 2012;3:153\u201373. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2012.030.","journal-title":"J Gastrointest Oncol"},{"key":"4269_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/his.13748","volume":"74","author":"RS Gonzalez","year":"2019","unstructured":"Gonzalez RS, Cates JMM, Washington K. Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component. Histopathology. 2019;74:406\u201314. https:\/\/doi.org\/10.1111\/his.13748.","journal-title":"Histopathology"},{"key":"4269_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02054","volume":"11","author":"JA Grondin","year":"2020","unstructured":"Grondin JA, Kwon YH, Far PM,\u00a0Haq S, Khan WI. Mucins in intestinal mucosal defense and inflammation: learning from clinical and experimental studies. Front Immunol. 2020;11:2054. https:\/\/doi.org\/10.3389\/fimmu.2020.02054.","journal-title":"Front Immunol"},{"key":"4269_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X,\u00a0de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136. https:\/\/doi.org\/10.1038\/nm.3967.","journal-title":"Nat Med"},{"key":"4269_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163978","volume":"14","author":"Z Herold","year":"2022","unstructured":"Herold Z, Acs M, Szasz AM,\u00a0Olasz K, Hussong J, Mayr M, et al.  Patients with metachronous peritoneal metastatic mucinous colorectal adenocarcinoma benefit more from cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) than their synchronous counterparts. Cancers Basel. 2022;14:3978. https:\/\/doi.org\/10.3390\/cancers14163978.","journal-title":"Cancers Basel"},{"key":"4269_CR11","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.4240\/wjgs.v13.i12.1567","volume":"13","author":"A Huang","year":"2021","unstructured":"Huang A, Yang Y, Shi J-Y, Li YK, Xu JX, Cheng Y, et al. Mucinous adenocarcinoma: a unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg. 2021;13:1567\u201383. https:\/\/doi.org\/10.4240\/wjgs.v13.i12.1567.","journal-title":"World J Gastrointest Surg"},{"key":"4269_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrclinonc.2015.140","volume":"13","author":"N Hugen","year":"2016","unstructured":"Hugen N, Brown G, Glynne-Jones R,\u00a0de Wilt JH, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol. 2016;13:361\u20139. https:\/\/doi.org\/10.1038\/nrclinonc.2015.140.","journal-title":"Nat Rev Clin Oncol"},{"key":"4269_CR13","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1245\/s10434-014-3706-6","volume":"21","author":"N Hugen","year":"2014","unstructured":"Hugen N, Van Beek JJP, De Wilt JHW, Nagtegaal ID. Insight into mucinous colorectal carcinoma: clues from etiology. Ann Surg Oncol. 2014;21:2963\u201370. https:\/\/doi.org\/10.1245\/s10434-014-3706-6.","journal-title":"Ann Surg Oncol"},{"key":"4269_CR14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.4251\/wjgo.v15.i8.1461","volume":"15","author":"J Jiang","year":"2023","unstructured":"Jiang J, Tang X-W, Huang S,\u00a0Hu N, Chen Y, Luo B, et al.  Epidemiologic characteristics and risk factors associated with overall survival for patients with mucinous colorectal cancer: a population-based study. World J Gastrointest Oncol. 2023;15:1461\u201374. https:\/\/doi.org\/10.4251\/wjgo.v15.i8.1461.","journal-title":"World J Gastrointest Oncol"},{"key":"4269_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/bjc.2016.211","volume":"115","author":"JH Kim","year":"2016","unstructured":"Kim JH, Park HE, Cho N-Y,\u00a0Lee HS, Kang GH. Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers. Br J Cancer. 2016;115:490\u20136. https:\/\/doi.org\/10.1038\/bjc.2016.211.","journal-title":"Br J Cancer"},{"key":"4269_CR16","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"T Le Dung","year":"2015","unstructured":"Le Dung T, Uram JN, Wang H,\u00a0Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372:2509\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1500596.","journal-title":"N Engl J Med"},{"key":"4269_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbcan.2019.05.009","volume":"1872","author":"S Li","year":"2019","unstructured":"Li S, Peppelenbosch MP, Smits R. Bacterial biofilms as a potential contributor to mucinous colorectal cancer formation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2019;1872:74\u20139. https:\/\/doi.org\/10.1016\/j.bbcan.2019.05.009.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"4269_CR18","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.01.52","volume":"8","author":"Z-P Li","year":"2020","unstructured":"Li Z-P, Liu X-Y, Kao X-M, Chen YT, Han SQ, Huang MX, et al. Clinicopathological characteristics and prognosis of colorectal mucinous adenocarcinoma and nonmucinous adenocarcinoma: a surveillance, epidemiology, and end results (SEER) population-based study. Ann Transl Med. 2020;8:205. https:\/\/doi.org\/10.21037\/atm.2020.01.52.","journal-title":"Ann Transl Med"},{"key":"4269_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/modpathol.2017.18","volume":"30","author":"C Liddell","year":"2017","unstructured":"Liddell C, Droy-Dupr\u00e9 L, M\u00e9tairie S, Airaud F, Volteau C, Bezieau S, et al. Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach. Mod Pathol. 2017;30:1177\u201389. https:\/\/doi.org\/10.1038\/modpathol.2017.18.","journal-title":"Mod Pathol"},{"key":"4269_CR20","doi-asserted-by":"publisher","first-page":"33935","DOI":"10.18632\/oncotarget.5223","volume":"6","author":"J Lin","year":"2015","unstructured":"Lin J, Qiu M, Xu R, Dobs AS. Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: results from the surveillance epidemiology and end results (SEER) database. Oncotarget. 2015;6:33935\u201343. https:\/\/doi.org\/10.18632\/oncotarget.5223.","journal-title":"Oncotarget"},{"key":"4269_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-019-0361-0","volume":"39","author":"C Luo","year":"2019","unstructured":"Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun. 2019;39:1\u201313. https:\/\/doi.org\/10.1186\/s40880-019-0361-0.","journal-title":"Cancer Commun"},{"key":"4269_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.clcc.2019.02.007","volume":"18","author":"R Moretto","year":"2019","unstructured":"Moretto R, Morano F, Ongaro E, Rossini D, Pietrantonio F, Casagrande M, et al. Lack of benefit from anti-EGFR treatment in RAS and BRAF wild-type metastatic colorectal cancer with mucinous histology or mucinous component. Clin Colorectal Cancer. 2019;18:116\u201324. https:\/\/doi.org\/10.1016\/j.clcc.2019.02.007.","journal-title":"Clin Colorectal Cancer"},{"key":"4269_CR23","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1245\/s10434-011-2174-5","volume":"19","author":"T Morikawa","year":"2012","unstructured":"Morikawa T, Kuchiba A, Qian ZR, Mino-Kenudson M, Hornick JL, Yamauchi M, et al. Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol. 2012;19:1944\u201353. https:\/\/doi.org\/10.1245\/s10434-011-2174-5.","journal-title":"Ann Surg Oncol"},{"key":"4269_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jcol.2018.09.001","volume":"39","author":"JR Murugesan","year":"2019","unstructured":"Murugesan JR, Murugesan SP, Yip J, Hitos K, Fulham S, Engel A.\u00a0Meta-analysis - perineural invasion as prognostic factor in rectal cancer. J Coloproctol (Rio J). 2019;39:74\u201380. https:\/\/doi.org\/10.1016\/j.jcol.2018.09.001.","journal-title":"J Coloproctol (Rio J)"},{"key":"4269_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D,\u00a0Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182\u20138. https:\/\/doi.org\/10.1111\/his.13975.","journal-title":"Histopathology"},{"key":"4269_CR26","first-page":"90","volume":"77","author":"D Parham","year":"1923","unstructured":"Parham D. Colloid carcinoma. Ann Surg. 1923;77:90\u2013105.","journal-title":"Ann Surg"},{"key":"4269_CR27","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1002\/cam4.5803","volume":"12","author":"C Patel","year":"2023","unstructured":"Patel C, Behring M, Al Diffalha S,\u00a0Dhall D, Lee G, Shanmugam C, et al. Immunophenotypic profiles and prognosis for colorectal mucinous adenocarcinomas are dependent on anatomic location. Cancer Med. 2023;12:9637\u201343. https:\/\/doi.org\/10.1002\/cam4.5803.","journal-title":"Cancer Med"},{"key":"4269_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/bjs.11142","volume":"106","author":"IS Reynolds","year":"2019","unstructured":"Reynolds IS, Furney SJ, Kay EW,\u00a0McNamara DA, Prehn JHM, Burke JP. Meta-analysis of the molecular associations of mucinous colorectal cancer. Br J Surg. 2019;106:682\u201391. https:\/\/doi.org\/10.1002\/bjs.11142.","journal-title":"Br J Surg"},{"key":"4269_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41397-019-0137-6","volume":"20","author":"IS Reynolds","year":"2020","unstructured":"Reynolds IS, O\u2019Connell E, Fichtner M,\u00a0McNamara DA, Kay EW, Prehn JHM, et al.  Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer. Pharmacogenomics J. 2020;20:524\u201332. https:\/\/doi.org\/10.1038\/s41397-019-0137-6.","journal-title":"Pharmacogenomics J"},{"key":"4269_CR30","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3892\/or.2012.1626","volume":"27","author":"N Sato","year":"2012","unstructured":"Sato N, Saga Y, Mizukami H,\u00a0Wang D, Fujiwara H, Takei Y, et al. Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations. Oncol Rep. 2012;27:1336\u201340. https:\/\/doi.org\/10.3892\/or.2012.1626.","journal-title":"Oncol Rep"},{"key":"4269_CR31","first-page":"1486","volume":"122","author":"W Song","year":"2009","unstructured":"Song W, Wu SJ, He YL, Cai SR, Zhang CH, Zhang XH, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 2009 Jul 5;122(13):1486-91. PMID: 19719934.","journal-title":"Chin Med J (Engl)"},{"key":"4269_CR32","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/modpathol.2008.170","volume":"21","author":"CO Sung","year":"2008","unstructured":"Sung CO, Seo JW, Kim KM, Do IG, Kim SW, Park CK. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol. 2008 Dec;21(12):1533-41. doi: 10.1038\/modpathol.2008.170.","journal-title":"Mod Pathol"},{"key":"4269_CR33","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1046\/j.0007-1323.2001.01810.x","volume":"88","author":"H Ueno","year":"2001","unstructured":"Ueno H, Hase K, Mochizuki H. Criteria for extramural perineural invasion as a prognostic factor in rectal cancer. Br J Surg. 2001;88:994\u20131000. https:\/\/doi.org\/10.1046\/j.0007-1323.2001.01810.x.","journal-title":"Br J Surg"},{"key":"4269_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/bjs.1800720915","volume":"72","author":"HC Umpleby","year":"1985","unstructured":"Umpleby HC, Ranson DL, Williamson RC. Peculiarities of mucinous colorectal carcinoma. Br J Surg. 1985;72:715\u20138. https:\/\/doi.org\/10.1002\/bjs.1800720915.","journal-title":"Br J Surg"},{"key":"4269_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/modpathol.2012.150","volume":"26","author":"A Voutsina","year":"2013","unstructured":"Voutsina A, Tzardi M, Kalikaki A, Zafeiriou Z, Papadimitraki E, Papadakis M, et al.\u00a0Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer. Mod Pathol. 2013;26:302\u201313. https:\/\/doi.org\/10.1038\/modpathol.2012.150.","journal-title":"Mod Pathol"},{"key":"4269_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/oncolo\/oyab028","volume":"27","author":"C Wang","year":"2022","unstructured":"Wang C, Sandhu J, Fakih M. Mucinous histology is associated with resistance to anti-EGFR therapy in patients with left-sided RAS\/BRAF wild-type metastatic colorectal cancer. Oncologist. 2022;27:104\u20139. https:\/\/doi.org\/10.1093\/oncolo\/oyab028.","journal-title":"Oncologist"},{"key":"4269_CR37","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.21873\/anticanres.14115","volume":"40","author":"L Wang","year":"2020","unstructured":"Wang L, Hirano Y, Heng G, Ishii T, Kondo H, Hara K, et al. Mucinous adenocarcinoma as a high-risk factor in Stage II colorectal cancer: a propensity score-matched study from Japan. Anticancer Res. 2020;40:1651\u20139. https:\/\/doi.org\/10.21873\/anticanres.14115.","journal-title":"Anticancer Res"},{"key":"4269_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5483\/BMBRep.2021.54.7.064","volume":"54","author":"D-H Wi","year":"2021","unstructured":"Wi D-H, Cha J-H, Jung Y-S. Mucin in cancer: a stealth cloak for cancer cells. BMB Rep. 2021;54:344\u201355. https:\/\/doi.org\/10.5483\/BMBRep.2021.54.7.064.","journal-title":"BMB Rep"},{"key":"4269_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02059-w","volume":"40","author":"M Xu","year":"2023","unstructured":"Xu M, Hao Y, Zhou H,\u00a0Shi Z, Si J, Song Z.  Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study. Med Oncol. 2023;40:198. https:\/\/doi.org\/10.1007\/s12032-023-02059-w.","journal-title":"Med Oncol"},{"key":"4269_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09031-9","volume":"21","author":"C Yan","year":"2021","unstructured":"Yan C, Yang H, Chen L, Liu R, Shang W, Yuan W, et al. Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study. BMC Cancer. 2021;21:1286. https:\/\/doi.org\/10.1186\/s12885-021-09031-9.","journal-title":"BMC Cancer"},{"key":"4269_CR41","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1158\/1078-0432.CCR-06-0202","volume":"12","author":"J-F You","year":"2006","unstructured":"You JF, Hsieh LL, Changchien CR, Chen JS, Chen JR, Chiang JM, et al.\u00a0Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. Clin Cancer Res. 2006;12:4244\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0202.","journal-title":"Clin Cancer Res"},{"key":"4269_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/pcmedi\/pbab002","volume":"4","author":"K Zhao","year":"2021","unstructured":"Zhao K, Wu L, Huang Y, Yao S, Xu Z, Lin H, et al. Deep learning quantified mucus-tumor ratio predicting survival of patients with colorectal cancer using whole-slide images. Precis Clin Med. 2021;4:17\u201324. https:\/\/doi.org\/10.1093\/pcmedi\/pbab002.","journal-title":"Precis Clin Med"},{"key":"4269_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.1609800","volume":"27","author":"L Zhu","year":"2021","unstructured":"Zhu L, Ling C, Xu T, Zhang J, Zhang Y, Liu Y, et al.\u00a0Clinicopathological features and survival of signet-ring cell carcinoma and mucinous adenocarcinoma of right colon, left colon, and rectum. Pathol Oncol Res. 2021;27:1609800. https:\/\/doi.org\/10.3389\/pore.2021.1609800.","journal-title":"Pathol Oncol Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04269-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04269-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04269-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:41:43Z","timestamp":1790160103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04269-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04269-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}